Lex Aurum Advisors, LLC Gsk PLC Transaction History

Lex Aurum Advisors, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 Apr 22, 2020	SELL	$32.47 - $48.83 $142,543 - $214,363	-4,390 Closed	0 $0
Q4 2019 Jan 27, 2020	BUY	$42.0 - $48.25 $184,380 - $211,817	4,390 New	4,390 $206,000
Q2 2019 Jul 19, 2019	SELL	$39.4 - $42.7 $195,424 - $211,792	-4,960 Closed	0 $0
Q1 2019 May 03, 2019	SELL	$38.57 - $42.69 $108,960 - $120,599	-2,825 Reduced 36.29%	4,960 $207,000
Q4 2018 Feb 07, 2019	BUY	$37.8 - $42.69 $8,316 - $9,391	220 Added 2.91%	7,785 $297,000
Q3 2018 Nov 09, 2018	SELL	$39.75 - $42.69 $16,695 - $17,929	-420 Reduced 5.26%	7,565 $304,000
Q2 2018 Aug 07, 2018	SELL	$39.61 - $42.76 $3,961 - $4,276	-100 Reduced 1.24%	7,985 $322,000
Q1 2018 May 09, 2018	BUY	$36.18 - $40.15 $40,883 - $45,369	1,130 Added 16.25%	8,085 $316,000
Q4 2017 Feb 09, 2018	BUY	$35.34 - $41.9 $245,789 - $291,414	6,955	6,955 $261,000

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.4B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Lex Aurum Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Lex Aurum Advisors, LLC with notifications on news.